Surgical & Cosmetic Dermatology is an interdisciplinary open-access journal dedicated to publishing research on all aspects of Dermatologic Surgery. It also welcomes articles in Dermatologic and Cosmetic Surgery, Cutaneous Oncology, Images in Dermatology, Cosmetic Dermatology, Laser and Others Technologies in Dermatology
The journal adopts the continuous publication model. It means that the manuscript is released online as soon as it is ready to be published, creating a rapid flow of quality articles and resulting in faster access.
Submission of a paper to Surgical & Cosmetic Dermatology implies that all authors have read and agreed to its content, that the manuscript conforms to the journal’s policies, and that it has not been previously published or is not currently being considered for publication elsewhere.
It is also worth considering that Surgical & Cosmetic Dermatology supports the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. (http://www.icmje.org/recommendations/)
It is also worth considering that Surgical & Cosmetic Dermatology supports the:
All submitted manuscripts must be in English and Portuguese (just for Portuguese language authors). The text must be submitted in grammatically correct English to facilitate proper peer reviewing. If the authors are not native English speakers, we recommend that the manuscript is professionally edited before submission or read by a native English-speaking colleague.
All articles published by Surgical & Cosmetic Dermatology are made immediately available worldwide, which means that: everyone has free and unlimited access to the full text of all articles published; everyone is free to re-use the published material if proper accreditation/citation of the original publication is given; and open access publication is supported by Brazilian Societies of Dermatology and Dermatologic Surgery. So, the authors will not need to pay any Article Processing Charge (APC) for accepted and published articles.
Authors are expected to fulfill the four criteria established by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html):
(1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;
(2) Drafting the work or revising it critically for important intellectual content;
(3) Final approval of the version to be published;
(4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributors that do not meet the criteria for authorship should be listed in the ‘Acknowledgements’ section. Each author must describe their role in the manuscript. The corresponding author is responsible for ensuring that all authors have agreed to the submission of the manuscript, but all of them should take responsibility for its content.
The list of authors should be carefully analyzed when submitting the manuscript. Any change (addition or removal of authors) during the evaluation process must have a reasonable and robust explanation in addition to a signed agreement of all authors. Authorship changes are not allowed after acceptance of the article.
Peer-review is the system used to evaluate the quality of a manuscript before its publication. Independent researchers in the research area assess submitted manuscripts for originality, validity, and significance to help editors determine whether the manuscript should be published. Surgical & Cosmetic Dermatology uses a double-blind peer-review system, where the reviewers do not know the names or affiliations of the authors, and the reviewer reports provided to the authors are anonymous. The suitability of a manuscript for publication is assessed solely on criteria of scientific excellence. The editor-in-chief makes final decisions.
All content the journal, except where identified, is under a Creative Commons Attribution-Non Commercial 4.0 International license. According to the Creative Commons license definitions, CC–BY 4.0 "lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. (https://creativecommons.org/licenses/?lang=en)
When reporting on a study that involves human subjects or human material, authors must declare that they had obtained approval from an ethics committee before undertaking the research. The article should cite a statement including the project identification code, date of acceptance, and name of the ethics committee or institutional review board.
Clinical trials or randomized controlled trials must be registered in a primary record of the WHO International Clinical Trials Registry Platform (https://www.who.int/clinical-trials-registry-platform).
Any experimental work using animals must conform to the principles of animal welfare in experimental science. Reference must be made to principles of laboratory animal care or similar regulations. The article must include the approval by a properly constituted research ethics committee containing the following data: project identification code, date of acceptance, and name of the ethics committee or institutional review board.
Authors must ensure that the reported research is not the result of misconduct such as data fabrication, falsification, plagiarism, or duplication. In case of confirmed misconduct, the journal will issue a retraction notice to correct the scientific record. All manuscripts are submitted to plagiarism detection software to prevent misconduct and ensure written work's originality.
All content the journal, except where identified, is under a Creative Commons Attribution-NonCommercial 4.0 International license - ISSN-e 1984-8773
